vs
Side-by-side financial comparison of Elme Communities (ELME) and MEDIFAST INC (MED). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $62.1M, roughly 1.2× Elme Communities). On growth, Elme Communities posted the faster year-over-year revenue change (1.7% vs -36.9%). Elme Communities produced more free cash flow last quarter ($7.2M vs $-6.6M). Over the past eight quarters, Elme Communities's revenue compounded faster (2.7% CAGR vs -34.4%).
Elme Communities is a publicly traded U.S. real estate investment trust that primarily owns, operates and develops high-quality multifamily residential communities. It focuses on key growth markets across the U.S. Mid-Atlantic and Southeast, offering affordable to mid-tier housing options for diverse renter groups.
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
ELME vs MED — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $75.1M |
| Net Profit | $-123.5M | — |
| Gross Margin | 61.1% | 69.4% |
| Operating Margin | -183.3% | -10.4% |
| Net Margin | -198.9% | — |
| Revenue YoY | 1.7% | -36.9% |
| Net Profit YoY | -4058.7% | — |
| EPS (diluted) | $-1.40 | $-1.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $75.1M | ||
| Q3 25 | $62.1M | $89.4M | ||
| Q2 25 | $62.1M | $105.6M | ||
| Q1 25 | $61.5M | $115.7M | ||
| Q4 24 | $61.3M | $119.0M | ||
| Q3 24 | $61.1M | $140.2M | ||
| Q2 24 | $60.1M | $168.6M | ||
| Q1 24 | $59.5M | $174.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-123.5M | $-2.3M | ||
| Q2 25 | $-3.6M | $2.5M | ||
| Q1 25 | $-4.7M | $-772.0K | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $-3.0M | $1.1M | ||
| Q2 24 | $-3.5M | $-8.2M | ||
| Q1 24 | $-3.6M | $8.3M |
| Q4 25 | — | 69.4% | ||
| Q3 25 | 61.1% | 69.5% | ||
| Q2 25 | 63.5% | 72.6% | ||
| Q1 25 | 64.2% | 72.8% | ||
| Q4 24 | 62.9% | 74.1% | ||
| Q3 24 | 63.5% | 75.4% | ||
| Q2 24 | 63.4% | 73.2% | ||
| Q1 24 | 63.5% | 72.8% |
| Q4 25 | — | -10.4% | ||
| Q3 25 | -183.3% | -4.6% | ||
| Q2 25 | 9.6% | -1.0% | ||
| Q1 25 | 7.8% | -1.1% | ||
| Q4 24 | 10.4% | 0.6% | ||
| Q3 24 | 11.0% | 1.5% | ||
| Q2 24 | 9.8% | -4.7% | ||
| Q1 24 | 7.5% | 4.5% |
| Q4 25 | — | — | ||
| Q3 25 | -198.9% | -2.5% | ||
| Q2 25 | -5.7% | 2.3% | ||
| Q1 25 | -7.6% | -0.7% | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | -4.9% | 0.8% | ||
| Q2 24 | -5.8% | -4.8% | ||
| Q1 24 | -6.1% | 4.8% |
| Q4 25 | — | $-1.64 | ||
| Q3 25 | $-1.40 | $-0.21 | ||
| Q2 25 | $-0.04 | $0.22 | ||
| Q1 25 | $-0.05 | $-0.07 | ||
| Q4 24 | $-0.04 | $0.08 | ||
| Q3 24 | $-0.03 | $0.10 | ||
| Q2 24 | $-0.04 | $-0.75 | ||
| Q1 24 | $-0.04 | $0.76 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1M | $167.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $908.9M | $198.9M |
| Total Assets | $1.7B | $248.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $167.3M | ||
| Q3 25 | $7.1M | $173.5M | ||
| Q2 25 | $4.8M | $162.7M | ||
| Q1 25 | $6.4M | $164.6M | ||
| Q4 24 | $6.1M | $162.3M | ||
| Q3 24 | $4.8M | $170.0M | ||
| Q2 24 | $5.6M | $163.5M | ||
| Q1 24 | $4.2M | $156.4M |
| Q4 25 | — | $198.9M | ||
| Q3 25 | $908.9M | $214.7M | ||
| Q2 25 | $1.0B | $216.0M | ||
| Q1 25 | $1.1B | $211.0M | ||
| Q4 24 | $1.1B | $210.1M | ||
| Q3 24 | $1.1B | $207.3M | ||
| Q2 24 | $1.1B | $205.3M | ||
| Q1 24 | $1.1B | $211.0M |
| Q4 25 | — | $248.0M | ||
| Q3 25 | $1.7B | $268.2M | ||
| Q2 25 | $1.8B | $269.3M | ||
| Q1 25 | $1.8B | $280.0M | ||
| Q4 24 | $1.8B | $284.2M | ||
| Q3 24 | $1.9B | $291.2M | ||
| Q2 24 | $1.9B | $293.5M | ||
| Q1 24 | $1.9B | $302.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.9M | $-5.3M |
| Free Cash FlowOCF − Capex | $7.2M | $-6.6M |
| FCF MarginFCF / Revenue | 11.6% | -8.8% |
| Capex IntensityCapex / Revenue | 14.0% | 1.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $86.7M | $1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-5.3M | ||
| Q3 25 | $15.9M | $12.1M | ||
| Q2 25 | $29.8M | $-3.4M | ||
| Q1 25 | $16.2M | $3.4M | ||
| Q4 24 | $95.2M | $-4.9M | ||
| Q3 24 | $20.7M | $9.1M | ||
| Q2 24 | $28.9M | $13.1M | ||
| Q1 24 | $21.2M | $7.3M |
| Q4 25 | — | $-6.6M | ||
| Q3 25 | $7.2M | $10.8M | ||
| Q2 25 | $21.1M | $-4.8M | ||
| Q1 25 | $10.5M | $1.9M | ||
| Q4 24 | $47.9M | $-7.2M | ||
| Q3 24 | $8.8M | $7.7M | ||
| Q2 24 | $21.0M | $11.1M | ||
| Q1 24 | $7.6M | $5.4M |
| Q4 25 | — | -8.8% | ||
| Q3 25 | 11.6% | 12.0% | ||
| Q2 25 | 34.1% | -4.5% | ||
| Q1 25 | 17.1% | 1.6% | ||
| Q4 24 | 78.1% | -6.1% | ||
| Q3 24 | 14.4% | 5.5% | ||
| Q2 24 | 34.9% | 6.6% | ||
| Q1 24 | 12.8% | 3.1% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | 14.0% | 1.5% | ||
| Q2 25 | 14.0% | 1.3% | ||
| Q1 25 | 9.2% | 1.3% | ||
| Q4 24 | 77.4% | 1.9% | ||
| Q3 24 | 19.4% | 1.0% | ||
| Q2 24 | 13.1% | 1.1% | ||
| Q1 24 | 22.9% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.36× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.04× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
MED
Segment breakdown not available.
